World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Best Female Scientists 107 1011 963 28 26 625 44341
Medicine 109 5740 5388 214 210 624 47766

Elisabeth G.E. de Vries publications per year

The chart shows the history of publications by Elisabeth G.E. de Vries between 1985 and 2026, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Elisabeth G.E. de Vries published across 42 years, from 1985 to 2026, averaging 21.4 papers a year. Output peaked at 173 publications in 2023. 53 of the 899 publications appeared in the last two years.

No. of publications
50 100 150
Bar chart. Horizontal axis: year, 1985 to 2026. Vertical axis: number of publications, 0 to 173. Peak 173 publications in 2023. 1985: 4 publications 1986: 2 publications 1987: 1 publication 1988: 1 publication 1989: 2 publications 1990: 6 publications 1991: 9 publications 1992: 5 publications 1993: 1 publication 1994: 3 publications 1995: 5 publications 1996: 8 publications 1997: 8 publications 1998: 9 publications 1999: 16 publications 2000: 12 publications 2001: 11 publications 2002: 17 publications 2003: 20 publications 2004: 27 publications 2005: 28 publications 2006: 20 publications 2007: 18 publications 2008: 20 publications 2009: 29 publications 2010: 20 publications 2011: 25 publications 2012: 23 publications 2013: 21 publications 2014: 36 publications 2015: 35 publications 2016: 26 publications 2017: 29 publications 2018: 40 publications 2019: 29 publications 2020: 34 publications 2021: 21 publications 2022: 27 publications 2023: 173 publications 2024: 25 publications 2025: 52 publications 2026: 1 publication
1985 2026

899 publications in total across all disciplines

View publications per year as a table
Elisabeth G.E. de Vries: publications per year, 1985 to 2026
Year Publications
1985 4
1986 2
1987 1
1988 1
1989 2
1990 6
1991 9
1992 5
1993 1
1994 3
1995 5
1996 8
1997 8
1998 9
1999 16
2000 12
2001 11
2002 17
2003 20
2004 27
2005 28
2006 20
2007 18
2008 20
2009 29
2010 20
2011 25
2012 23
2013 21
2014 36
2015 35
2016 26
2017 29
2018 40
2019 29
2020 34
2021 21
2022 27
2023 173
2024 25
2025 52
2026 1
Total 899
Download as CSV

Elisabeth G.E. de Vries publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Elisabeth G.E. de Vries sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 621–640 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 624 publications — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386 624
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Elisabeth G.E. de Vries D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Elisabeth G.E. de Vries sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 108–109 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 109 D-Index — 72nd percentile

72% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445 109
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Elisabeth G.E. de Vries is affiliated with the University Medical Center Groningen in the Netherlands. Their research primarily revolves around the field of medicine, with a strong focus on oncology and radiology, nuclear medicine, and imaging. Additional research interests extend into economics and econometrics, molecular biology, and pulmonary and respiratory medicine.

The scientist's work covers several main topics, including:

  • Cancer Immunotherapy and Biomarkers
  • Medical Imaging Techniques and Applications
  • Economic and Financial Impacts of Cancer
  • Radiopharmaceutical Chemistry and Applications
  • CAR-T cell therapy research
  • Health Systems, Economic Evaluations, Quality of Life
  • Monoclonal and Polyclonal Antibodies Research

Frequent co-authors collaborating with Elisabeth G.E. de Vries include:

  • Rudolf S.N. Fehrmann (27 joint publications)
  • Sjoukje F. Oosting (26 joint publications)
  • Adrienne H. Brouwers (25 joint publications)
  • Mathilde Jalving (23 joint publications)
  • Geke A.P. Hospers (18 joint publications)

Their research has been regularly published in several notable scientific venues, among which the most frequent are:

  • Annals of Oncology (15 publications)
  • Clinical Cancer Research (10 publications)
  • Journal of Nuclear Medicine (9 publications)
  • ESMO Open (9 publications)
  • The Lancet Oncology (7 publications)

Selected recent papers include:

  • "Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma," 2022, Nature Medicine
  • "Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus," 2020, Annals of Oncology
  • "COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety," 2022, Nature Reviews Clinical Oncology
  • "Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey," 2021, The Lancet Oncology
  • "Whole-body CD8+ T cell visualization before and during cancer immunotherapy: a phase 1/2 trial," 2022, Nature Medicine

Best Publications

  • Everolimus for Advanced Pancreatic Neuroendocrine Tumors

    James C. Yao;Manisha H. Shah;Tetsuhide Ito;Catherine Lombard Bohas

  • iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics

    Lesley Seymour;Jan Bogaerts;Andrea Perrone;Robert Ford

  • RECIST 1.1—Update and clarification: From the RECIST committee

    Lawrence H. Schwartz;Lawrence H. Schwartz;Saskia Litiere;Elisabeth G. E. de Vries;Robert Ford

  • Response assessment criteria for brain metastases: proposal from the RANO group

    Nancy U Lin;Eudocia Q Lee;Hidefumi Aoyama;Igor J Barani

  • Evidence based selection of housekeeping genes

    Hendrik J. M. de Jonge;Rudolf S. N. Fehrmann;Eveline S. J. M. de Bont;Robert M. W. Hofstra

  • A review on CXCR4/CXCL12 axis in oncology: No place to hide

    Urszula M. Domanska;Roeliene C. Kruizinga;Wouter B. Nagengast;Hetty Timmer-Bosscha

  • 89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer

    Frederike Bensch;Elly L. van der Veen;Marjolijn N. Lub-de Hooge;Annelies Jorritsma-Smit

  • Metformin: taking away the candy for cancer?

    Mathilde Jalving;Jourik A. Gietema;Joop D. Lefrandt;Steven de Jong

  • Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study.

    Udai Banerji;Carla M L van Herpen;Cristina Saura;Fiona Thistlethwaite

  • Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro.

    Mwn Nijsten;P Olinga;Ege de Vries

  • Indium-111–Labeled Trastuzumab Scintigraphy in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer

    Patrick J. Perik;Marjolijn N. Lub-De Hooge;Jourik A. Gietema;Winette T.A. van der Graaf

  • In Vivo VEGF Imaging with Radiolabeled Bevacizumab in a Human Ovarian Tumor Xenograft

    Wouter B. Nagengast;Elisabeth G. de Vries;Geke A. Hospers;Nanno H. Mulder

  • Increased cancer risk after liver transplantation: a population-based study.

    Elizabeth B Haagsma;Vincent E Hagens;Michael Schaapveld;Aad P van den Berg

  • Gene expression analysis identifies global gene dosage sensitivity in cancer

    Rudolf S. N. Fehrmann;Juha M. Karjalainen;Małgorzata Krajewska;Harm-Jan Westra

  • Development and characterization of clinical-grade 89Zr-trastuzumab for HER2/neu immunoPET imaging.

    Eli C. F. Dijkers;Jos G. W. Kosterink;Anna P. Rademaker;Lars R. Perk

  • Immuno-PET: A Navigator in Monoclonal Antibody Development and Applications

    Guus A.M.S. van Dongen;Gerard W.M. Visser;Marjolijn N. Lub-de Hooge;Elisabeth G. de Vries

  • Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma.

    Mirjam J. A. Engelen;Henrike E. Kos;Pax H. B. Willemse;Jan G. Aalders

  • Tumor-associated macrophages in breast cancer : Innocent bystander or important player?

    Si-Qi Qiu;Stijn J.H. Waaijer;Mieke C. Zwager;Elisabeth G.E. de Vries

  • Relevance of Tumor-Infiltrating Immune Cell Composition and Functionality for Disease Outcome in Breast Cancer.

    Rico Rd Bense;Christos Sotiriou;Martine Piccart-Gebhart;John B A G Jb Haanen

  • Molecular and Clinical Characteristics of MSH6 Variants: An Analysis of 25 Index Carriers of a Germline Variant

    Maran J.W. Berends;Ying Wu;Rolf H. Sijmons;Rob G.J. Mensink

Frequent Co-Authors

Harry Hollema
Harry Hollema University Medical Center Groningen
Jan H. Kleibeuker
Jan H. Kleibeuker University Medical Center Groningen
Edo Vellenga
Edo Vellenga University Medical Center Groningen
Harry J.M. Groen
Harry J.M. Groen University Medical Center Groningen
Gerard J. te Meerman
Gerard J. te Meerman University Medical Center Groningen
Rudi Dierckx
Rudi Dierckx University Medical Center Groningen
Otto S. Hoekstra
Otto S. Hoekstra Amsterdam UMC
Robert M.W. Hofstra
Robert M.W. Hofstra Erasmus University Rotterdam
Henk M.W. Verheul
Henk M.W. Verheul Radboud University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in Medicine doesn’t always mean becoming a physician. There are diverse online degree options in healthcare, each with unique pathways, time commitments, and admission requirements.

If you’re interested in healthcare administration, explore cahme accredited online mha programs, which prepare you for leadership roles in hospitals and healthcare systems. For registered nurses seeking career advancement, some rn to bsn programs without clinicals allow you to finish your bachelor’s degree entirely online, offering flexibility for working professionals.

Ambitious nurses can fast-track their education with shortest dnp programs online, earning a Doctor of Nursing Practice quickly to qualify for top clinical or leadership roles. If you prioritize accessibility and support, community ratings highlight some as the easiest dnp program reddit options, ideal if you’re searching for smoother journeys through advanced practice education.

Exploring these alternative online healthcare degrees can help you find the best fit for your goals, balancing convenience, career progression, and your personal circumstances.

Best Scientists Citing Elisabeth G.E. de Vries

Trending Scientists

Recently Published Articles